Skip to main content
Premium Trial:

Request an Annual Quote

Waters Receives $250M Loan; Will Buy Back Stock, Pay for General Expenses

NEW YORK, Nov. 30 (GenomeWeb News) - Waters has borrowed $250 million on Nov. 28 as part of a new term loan facility administered by JPMorgan Chase Bank and other financial institutions, the company disclosed today in a filing with the Securities and Exchange Commission.

 

Waters expects to use the cash to buy back common stock under its stock-repurchase program and for "general corporate purposes," the filing said.

 

The term matures on Nov. 28, 2010, and requires no scheduled repayments beforehand, but prepayments can be made.

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.